Some Use Of Drug From Covidien Ltd May Up Leukemia Risk, FDA Reports

WASHINGTON (Reuters) - Covidien Ltd has warned doctors its injectable drug, Phosphocol P 32, may increase the risk for leukemia when used to treat conditions not approved by U.S. regulators, the Food and Drug Administration said on Thursday.